Sign in

NCT05321745Recruiting

Fecal Microbiota Transplantation in Pediatric Crohn's Disease

Repeated and Periodic Fecal Microbiota Transplantation in Children With Active and Refractory Crohn's Disease

Source: ClinicalTrials.gov · Last updated 10 Jul 2026

Brief summary (registry, in English)

This study will test the safety and effectiveness of fecal microbiota transplantation (FMT) plus partial enteral nutrition (PEN) in refractory pediatric Crohn's disease (CD) who have failed conventional treatment

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
4 Apr 2022
Start date
22 Mar 2022
Primary completion date
31 May 2027
Lead sponsor
Biao Zou
NCT number
NCT05321745

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 22 Mar 2022 to the primary completion date, 31 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Aged 2-16 years and without genetic diseases; All refractory pediatric with mild-to-moderate CD; Mild-to-moderate CD, defined by the pediatric Crohn's disease activity index (PCDAI) \>10 and ≤40 and Simple Endoscopic Score for CD (SES-CD) \> 3 were enrolled in the study; refractory CD, defined by children who failed conventional treatment (hormone, immunosuppressant, biologics)

Age in the registry: 2 years to 16 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Tongji Hospital
Coordinator of this site? Confirm its status		WuhanChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.